• Explore /
  • Poster
  • / Lenvatinib in recurrent hepatocellular carcinoma after liver transplantation.

Lenvatinib in recurrent hepatocellular carcinoma after liver transplantation.

Abstract Poster

Authors

Mehmet Akce

Mehmet Akce

Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL

Mehmet Akce , Olumide B. Gbolahan , Jeffrey M. Switchenko , Mohamad B. Sonbol , Giorgio Roccaro , Robert M Cannon , Saulat S Sheikh , Olatunji B. Alese , Tanios S. Bekaii-Saab , Bassel F. El-Rayes

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05103904

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr TPS578)

DOI

10.1200/JCO.2024.42.3_suppl.TPS578

Abstract #

TPS578

Poster Bd #

P7

Abstract Disclosures

Similar Posters

First Author: Jia-Yi Wu

First Author: Lorenza Rimassa

First Author: Yongkang Xu

First Author: Takeshi Terashima